[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,459,890
  • Shares Outstanding, K 107,352
  • Annual Sales, $ 761,410 K
  • Annual Income, $ 99,650 K
  • EBIT $ -8 M
  • EBITDA $ -11 M
  • 60-Month Beta 0.36
  • Price/Sales 9.64
  • Price/Cash Flow 75.75
  • Price/Book 11.51

Options Overview Details

View History
  • Implied Volatility 50.04% (+0.72%)
  • Historical Volatility 56.71%
  • IV Percentile 27%
  • IV Rank 13.03%
  • IV High 138.94% on 12/15/25
  • IV Low 36.71% on 08/28/25
  • Expected Move (DTE 18) 5.36 (7.72%)
  • Put/Call Vol Ratio 1.21
  • Today's Volume 465
  • Volume Avg (30-Day) 1,510
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 22,797
  • Open Int (30-Day) 24,910
  • Expected Range 64.13 to 74.85

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.04
  • Number of Estimates 3
  • High Estimate $0.02
  • Low Estimate $-0.09
  • Prior Year $0.29
  • Growth Rate Est. (year over year) -113.79%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.73 +51.96%
on 04/30/26
69.90 -0.59%
on 05/28/26
+22.90 (+49.15%)
since 04/29/26
3-Month
31.81 +118.45%
on 03/13/26
69.90 -0.59%
on 05/28/26
+33.79 (+94.65%)
since 02/27/26
52-Week
28.66 +142.46%
on 02/19/26
91.00 -23.64%
on 10/08/25
-8.16 (-10.51%)
since 05/28/25

Most Recent Stories

More News
Corcept Presents New Data at ASCO 2026: Lifyorliâ„¢ Overall Survival Across All Subgroups of Patients with Platinum-Resistant Ovarian Cancer, Including Those with Recent Taxane Exposure

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic...

CORT : 69.49 (+1.62%)
Corcept to Resubmit its New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic...

CORT : 69.49 (+1.62%)
S&P 500 and Nasdaq 100 Post New Record Highs on Chip Stock Strength

The S&P 500 Index ($SPX ) (SPY ) on Wednesday closed up +0.58%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.04%. June E-mini...

GOOGL : 380.34 (-2.51%)
AAPL : 312.06 (-0.14%)
INTU : 331.53 (+5.92%)
ADI : 413.85 (-1.23%)
F : 17.44 (+4.74%)
WIX : 56.06 (+6.48%)
AKAM : 149.54 (+4.48%)
TXN : 305.68 (-3.25%)
$IUXX : 30,333.18 (+0.36%)
ASML : 1,612.76 (+0.44%)
ZNU26 : 109-265s (+0.03%)
MSFT : 450.24 (+5.45%)
Chip Stock Strength Lifts the Broader Market

The S&P 500 Index ($SPX ) (SPY ) today is up +0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.58%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.60%. June E-mini S&P futures (ESM26...

ADI : 413.85 (-1.23%)
WIX : 56.06 (+6.48%)
AKAM : 149.54 (+4.48%)
TXN : 305.68 (-3.25%)
$IUXX : 30,333.18 (+0.36%)
ZNU26 : 109-265s (+0.03%)
DT : 42.59 (+5.13%)
ESM26 : 7,595.75s (+0.18%)
QCOM : 251.02 (+3.18%)
$DOWI : 51,032.46 (+0.72%)
SPY : 756.48 (+0.25%)
DIA : 510.78 (+0.74%)
Stocks Pressured by Signs of Resurgent Inflation

The S&P 500 Index ($SPX ) (SPY ) today is down -0.19%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.47%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.05%. June E-mini S&P futures (ESM26...

ADI : 413.85 (-1.23%)
WIX : 56.06 (+6.48%)
AKAM : 149.54 (+4.48%)
$IUXX : 30,333.18 (+0.36%)
ZNU26 : 109-265s (+0.03%)
DT : 42.59 (+5.13%)
ESM26 : 7,595.75s (+0.18%)
LRCX : 318.18 (+0.06%)
$DOWI : 51,032.46 (+0.72%)
SPY : 756.48 (+0.25%)
DIA : 510.78 (+0.74%)
ON : 120.62 (-2.55%)
3 Reasons to Sell CORT and 1 Stock to Buy Instead

3 Reasons to Sell CORT and 1 Stock to Buy Instead

CORT : 69.49 (+1.62%)
3 High-Flying Stocks We Think Twice About

3 High-Flying Stocks We Think Twice About

CORT : 69.49 (+1.62%)
HIMX : 20.57 (-1.20%)
WMT : 115.75 (-2.65%)
CORT Q1 Deep Dive: Early Lifyorli Launch and Endocrinology Momentum Offset Margin Pressures

CORT Q1 Deep Dive: Early Lifyorli Launch and Endocrinology Momentum Offset Margin Pressures

CORT : 69.49 (+1.62%)
Corcept (NASDAQ:CORT) Misses Q1 CY2026 Revenue Estimates

Corcept (NASDAQ:CORT) Misses Q1 CY2026 Revenue Estimates

CORT : 69.49 (+1.62%)
Corcept: Q1 Earnings Snapshot

Corcept: Q1 Earnings Snapshot

CORT : 69.49 (+1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Corcept is focused on the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncology disorders which are associated with the activity of the hormone cortisol, also known as the stress hormone. Corcept's only marketed drug, Korlym (mifepristone),...

See More

Key Turning Points

3rd Resistance Point 71.64
2nd Resistance Point 70.63
1st Resistance Point 70.06
Last Price 69.49
1st Support Level 68.48
2nd Support Level 67.47
3rd Support Level 66.90

See More

52-Week High 91.00
Last Price 69.49
Fibonacci 61.8% 67.19
Fibonacci 50% 59.83
Fibonacci 38.2% 52.47
52-Week Low 28.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.